有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C21H28N4OS |
|
—— | 2-[(3,4-difluorophenyl)methylsulfanyl]-4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | N-cyclohexyl-2-[4-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C19H30N4OS |
|
—— | N-butyl-2-[4-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C17H28N4OS |
|
—— | 2-[4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetonitrile | —— | C13H18N4S |
|
—— | N-cyclohexyl-2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C19H30N4OS |
|
—— | N-cyclohexyl-2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C19H30N4OS |
|
—— | 1-[6-[(3,4-Difluorophenyl)methylsulfanyl]pyrimidin-4-yl]-3-methyl-4,5,6,7-tetrahydroindazole | —— | C19H18F2N4S |
|
—— | 4-(3,5-Dimethylpyrazol-1-yl)-6-[(3-fluorophenyl)methylsulfanyl]pyrimidine | —— | C16H15FN4S |
|
—— | 4-(3,5-Dimethylpyrazol-1-yl)-6-[(4-methylphenyl)methylsulfanyl]pyrimidine | —— | C17H18N4S |
|
—— | N-benzyl-N-ethyl-2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C23H27N5OS |
|
—— | 2-[6-(3,5-Dimethylpyrazol-1-yl)pyrimidin-4-yl]sulfanylacetonitrile | —— | C11H11N5S |
|
—— | 2-[6-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C19H21N5OS |
|
—— | Methyl 2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetate | —— | C15H18N4O2S |
|
—— | N-cyclohexyl-2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C20H27N5OS |
|
—— | 4-[(2,5-Difluorophenyl)methylsulfanyl]-6-(3,5-dimethylpyrazol-1-yl)pyrimidine | —— | C16H14F2N4S |
|
—— | 1-[6-[(2,5-Difluorophenyl)methylsulfanyl]pyrimidin-4-yl]-3-methyl-4,5,6,7-tetrahydroindazole | —— | C19H18F2N4S |
|
—— | 4-Benzylsulfanyl-6-(3,5-dimethylpyrazol-1-yl)pyrimidine | —— | C16H16N4S |
|
—— | 4-[(2,5-difluorophenyl)methylsulfanyl]-6-[(3S)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H19F2N3S |
|
—— | Methyl 2-[6-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-yl]sulfanylacetate | —— | C12H14N4O2S |
|
—— | N-[(4-fluorophenyl)methyl]-2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C21H22FN5OS |
|
—— | N-[(4-methylphenyl)methyl]-2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C22H25N5OS |
|
—— | 3-Methyl-1-[6-[(4-methylphenyl)methylsulfanyl]pyrimidin-4-yl]-4,5,6,7-tetrahydroindazole | —— | C20H22N4S |
|
—— | N-[2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethyl]acetamide | —— | C10H11N3O3S |
|
—— | 1-(6-Benzylsulfanylpyrimidin-4-yl)-3-methyl-4,5,6,7-tetrahydroindazole | —— | C19H20N4S |
|
—— | 1-[6-[(3-Fluorophenyl)methylsulfanyl]pyrimidin-4-yl]-3-methyl-4,5,6,7-tetrahydroindazole | —— | C19H19FN4S |
|
—— | 4-Benzylsulfanyl-6-(4-methylpiperidin-1-yl)pyrimidine | —— | C17H21N3S |
|
—— | N-butyl-2-[6-(3-methyl-4,5,6,7-tetrahydroindazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C18H25N5OS |
|
—— | 4-[(2,5-Difluorophenyl)methylsulfanyl]-6-(4-methylpiperidin-1-yl)pyrimidine | —— | C17H19F2N3S |
|
—— | N-benzyl-N-ethyl-2-[6-(4-methylpiperidin-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C21H28N4OS |
|
—— | N-butyl-2-[6-(4-methylpiperidin-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C16H26N4OS |
|
—— | N-cyclohexyl-2-[6-[(3R)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetamide | —— | C18H28N4OS |
|
—— | 4-[(4-methylphenyl)methylsulfanyl]-6-[(3S)-3-methylpiperidin-1-yl]pyrimidine | —— | C18H23N3S |
|
—— | Methyl 2-[6-(4-methylpiperidin-1-yl)pyrimidin-4-yl]sulfanylacetate | —— | C13H19N3O2S |
|
—— | 4-[(4-methylphenyl)methylsulfanyl]-6-[(3R)-3-methylpiperidin-1-yl]pyrimidine | —— | C18H23N3S |
|
—— | 2-[6-[(3S)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetonitrile | —— | C12H16N4S |
|
—— | N-[(4-fluorophenyl)methyl]-2-[6-(4-methylpiperidin-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C19H23FN4OS |
|
—— | 4-benzylsulfanyl-6-[(3S)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H21N3S |
|
—— | N-cyclohexyl-2-[6-[(3S)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetamide | —— | C18H28N4OS |
|
—— | 4-[(3-fluorophenyl)methylsulfanyl]-6-[(3S)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H20FN3S |
|
—— | N-[(4-fluorophenyl)methyl]-2-[6-[(3R)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetamide | —— | C19H23FN4OS |
|
—— | 4-[(3,4-difluorophenyl)methylsulfanyl]-6-[(3R)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H19F2N3S |
|
—— | methyl 2-[6-[(3S)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetate | —— | C13H19N3O2S |
|
—— | 2-[6-[(3R)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetonitrile | —— | C12H16N4S |
|
—— | methyl 2-[6-[(3R)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetate | —— | C13H19N3O2S |
|
—— | N-benzyl-N-ethyl-2-[6-[(3S)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetamide | —— | C21H28N4OS |
|
—— | N-cyclohexyl-2-[6-(4-methylpiperidin-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C18H28N4OS |
|
—— | N-benzyl-N-ethyl-2-[6-[(3R)-3-methylpiperidin-1-yl]pyrimidin-4-yl]sulfanylacetamide | —— | C21H28N4OS |
|
—— | 4-benzylsulfanyl-6-[(3R)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H21N3S |
|
—— | 4-[(2,5-difluorophenyl)methylsulfanyl]-6-[(3R)-3-methylpiperidin-1-yl]pyrimidine | —— | C17H19F2N3S |
|